chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On multiple unspecified dates, multiple unspecified patientes received improperly stored vaccine; No adverse effect; This spontaneous report has been received from a medical assistant, concerning a 19-week-old male patient.   The patient's concurrent conditions, historical conditions, previous drug reactions, or allergies and concomitant medication were not reported.  On 12-APR-2019, the patient was vaccinated with improper stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) ((dose, frequency, route of administration unknown) Lot#R016790 and expiration date 20-APR-2020 for prophylaxis. No adverse effects reported.  Additionally, temperature for vaccines were total time and highest temperature above 9°C (9.9 C); time frame: 4 hours; with no previous temperature excursion. The error was identified via a data logger.
1st vaccine - hour after vaccine administered, started having (L) eye/facial twitching and headache -> went away after about 4 days  2nd vaccine - same thing
I received a flu shot at approx 10:30 am on 12/12/2008. By approx 5:00PM I was very nauseous - by 8PM I was suffering from diarrhea, horrible sulfer - egg - smelling burping and gas, as well as coughing and some mild vomiting. I also am suffering from weakness and soreness - cannot sleep for more than 2 hrs at a time from above conditions. Still persisting as of 5 AM 12/15/2008. The only food I can keep down is toast and butter,k and it is quickly eliminated.
At 20 minutes of being monitored patient c/o chest tightness, pointed at below the breast level. BP: 180/108 P: 81. Patient stated being anxious and having history of anxiety. Offered patient more time to be monitored. Offered patient to be seen by urgent care but it was closed, offered patient to go the emergency room to be seen by an MD, patient declined. Patient was observed for a total of an hour, rechecked her BP: 137/80 P:71. Patient stated feeling a bit better. Patient spoke to our supervisor to let her know how she was doing. Patient stated feeling better, wanted to recheck BP one more time before heading home, BP:135/80 P: 76. Patient felt comfortable/safe enough to go home.
On 10/23/07. Pt c/o feeling tired 1-2 hrs after vaccination, congestion on L basal/side of face and tongue swelling. Felt some words were slurred and speech thick. (not observed today). Her injection site was sore-no redness or induration or swelling. no rashes. no wheezing.
Pt has recurrent right shoulder pain with soreness in the same area that she received her vaccine. It has been 3 mo since her vaccine and she gets this soreness every two weeks and it lasts for 2-3 days.
On 1/21/2021 I woke up and  felt a large lump by on left clavicle. It was about 1.5inch, tender, warm, smooth. I also had increased used of my albuterol inhaler due to shortness of breath. I went to the doctors. The started me on spariva and did a chest X-ray. They felt the lump was a swollen lymph node and to come back in two weeks if it remains swollen.
1 wk following vax pt devel t105 w/vomiting which lasted 24 hrs; mom took pt to MD & did have sl ear infect & was put on ATB;
This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 31Mar2021 at 08:00 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included asthmatic, blood pressure high and type 2 diabetes mellitus. The patient's concomitant medications included unspecified medications for asthmatic, high blood pressure and type 2 diabetes mellitus. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN) via an unspecified route of administration in the right arm on 10Mar2021 at 09:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021, on the day of vaccination, the patient experienced a very sore injection site area, itchy face-cheek and felt a little inflamed and fatigue. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events very sore injection site area, itchy face-cheek area, fatigue and inflammation was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
vaccinated on 06/18/2020 / not receive the second dose yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 18 June 2020, batch number 924T3).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of vaccination the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up . This case was linked with case US2021172401, reported by same reporter for different patient. The details were reported by 1st dose of Shingrix.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021172401:same reporter
Patient reported paresthesia the R arm/face and R sided facial droop. Patient went to primary physician which referred patient to Emergency Dept for further evaluation. Patient diagnosed with Bells Palsy.
This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in left arm in Mar2021 (at the age of 54-years old) as a single dose for COVID-19 immunisation. The patient's medical history included rheumatoid arthritis, shingles, herbal allergy (chamomile), ragweed allergy and fruit allergy (melon). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. In Apr2021, a week after receiving the second dose, the patient begun to experience neuralgic pains similar to those which she had experienced when she had shingles in the past year. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event, neuralgic pains was recovering at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
she broke out all over her body in a rash; splotches all over her body, feet, and hands; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN6206), dose 2 via an unspecified route of administration, administered in Arm Left on 04Mar2021 15:15 (received at the age of 75-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included heart disease, copd (chronic obstructive pulmonary disease), diabetes, and known allergies: adhesives, latex, strawberries. The patient was not pregnant. Concomitant medication(s) included losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported; gabapentin (GABAPENTIN) taken for an unspecified indication, start and stop date were not reported; potassium (POTASSIUM) taken for an unspecified indication, start and stop date were not reported; magnesium (MAGNESIUM) taken for an unspecified indication, start and stop date were not reported; rhodiola rosea (RHODIOLA ROSEA) taken for an unspecified indication, start and stop date were not reported; levothyroxine (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported; semaglutide (OZEMPIC) taken for an unspecified indication, start and stop date were not reported; atorvastatin (ATORVASTATIN) taken for an unspecified indication, start and stop date were not reported; vitamin k2 [menaquinone] (VITAMIN K2 [MENAQUINONE]) taken for an unspecified indication, start and stop date were not reported; cyanocobalamin (VITAMIN B-12) taken for an unspecified indication, start and stop date were not reported; vitamin d3 (VITAMIN D3) taken for an unspecified indication, start and stop date were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2) dose 1 via an unspecified route of administration, administered in Arm Left on 12Feb2021 15:15 (received at the age of 75-years-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient also received an unspecified "eye injection" in the left arm, in four weeks prior to receiving bnt162b2. The patient previously took phenobarbital and experienced allergy (known allergies: phenobarbital). The patient reported that she broke out all over her body in a rash and splotches all over her body, feet, and hands on 07Mar2021 15:00. Therapeutic measures were taken as a result of the adverse events which included prednisone, famotidine, over the counter antihistamine. Outcome of the events was recovering. The adverse events resulted into doctor or other healthcare professional office/clinic visit. The patient had no covid prior to vaccination and was not tested for covid post vaccination.   No follow-up attempts are possible. No further information is expected.
Redness travelled from upper left arm to under arm and to armpit. Extremely itchy,and feels almost bruised . As of today,March 15 2021, has not lessened and is still moving to underside of arm.
itchy; hot; a spot or two by her neck, around her panty line, on her back and under her right arm; break out left arm where she was vaccinated; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), FEELING HOT (hot), PIGMENTATION DISORDER (a spot or two by her neck, around her panty line, on her back and under her right arm) and VACCINATION SITE RASH (break out left arm where she was vaccinated) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 010A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced PRURITUS (itchy), FEELING HOT (hot), PIGMENTATION DISORDER (a spot or two by her neck, around her panty line, on her back and under her right arm) and VACCINATION SITE RASH (break out left arm where she was vaccinated). At the time of the report, PRURITUS (itchy), FEELING HOT (hot), PIGMENTATION DISORDER (a spot or two by her neck, around her panty line, on her back and under her right arm) and VACCINATION SITE RASH (break out left arm where she was vaccinated) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
syncope/fainted; Dizziness; couldn't eat; Fatigue/ tiredness; Sore arm; A spontaneous report was received from a consumer concerning herself, an 87-years old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced syncope/fainted, sore arm/pain in extremity, dizziness, fatigue/tiredness, and she couldn't eat (decreased appetite).   The patient's medical history included COVID-19 in December 2020.  Concomitant product use was not provided.   On 11 FEB 2021, 1 day prior to the onset of the events, the patient received their first dose of two planned doses of mRNA-1273 (lot/batch: 031L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 11 FEB 2021, the patient experienced sore arm.  On 12 FEB 2021, the patient experienced syncope (she fainted), dizziness, fatigue/tiredness, and she couldn't eat.   Treatment for the events included paracetamol.   Action taken with mRNA-1273 in response to the events was not reported.  The event of syncope/fainted was considered resolved on an unknown date.  The outcome of the events of sore arm, dizziness, fatigue/tiredness, and couldn't eat were unknown at the time of this report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Client notice an area of redness, slight swelling, and tenderness at site of influenza vaccination.  About "the size of a nickle" with a tiny pinpoint in the middle.  No recollection of a bug bite.  Advised client to call PMD if symptoms worsened or if she had futher concerns.  This writer will apprize health officer. Please note: administered via Bioject system.
Information has been received from a nurse practitioner concerning a male patient who on 01/14/2003 was vaccinated with a first dose of pneumococcal vaccine 23 polyvalent (Lot # 641532/1353L).  There were no concomitant medications.  On 01/14/2003 at 14:00 hours the patient's arm was red at the injection site.  The patient was seen on 01/16/2003 and the patient's arm was red, swollen and hot to the touch.  The patient experienced pain from the injection site to the "mid" of his forearm.  He was sent to urgent care for follow up.  Additional information has been requested.
cough; intermittent nausea; Injection site;pain,rash,itching,redness,swollen; Injection site;pain,rash,itching,redness,swollen; Injection site;pain,rash,itching,redness,swollen; general headache; Injection site;pain,rash,itching,redness,swollen; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), NAUSEA (intermittent nausea), VACCINATION SITE SWELLING (Injection site;pain,rash,itching,redness,swollen), VACCINATION SITE ERYTHEMA (Injection site;pain,rash,itching,redness,swollen) and VACCINATION SITE RASH (Injection site;pain,rash,itching,redness,swollen) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced COUGH (cough), NAUSEA (intermittent nausea), VACCINATION SITE SWELLING (Injection site;pain,rash,itching,redness,swollen), VACCINATION SITE ERYTHEMA (Injection site;pain,rash,itching,redness,swollen), VACCINATION SITE RASH (Injection site;pain,rash,itching,redness,swollen), HEADACHE (general headache) and VACCINATION SITE INDURATION (Injection site;pain,rash,itching,redness,swollen). At the time of the report, COUGH (cough), NAUSEA (intermittent nausea), VACCINATION SITE SWELLING (Injection site;pain,rash,itching,redness,swollen), VACCINATION SITE ERYTHEMA (Injection site;pain,rash,itching,redness,swollen), VACCINATION SITE RASH (Injection site;pain,rash,itching,redness,swollen), HEADACHE (general headache) and VACCINATION SITE INDURATION (Injection site;pain,rash,itching,redness,swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported. Treatment information not provided.
Mother noticed a rash on back 1 hr after immunizations were given. They looked like red blotches on entire back approximately the size of golf balls.
4 hours, post vax, pt developed dizziness and nausea. He vomited about 7 hours, post vax, developed diarrhea, nausea and vomiting and a temperature of 101F, by the next morning.
No adverse event; 26 doses administered to adult patients from pediatric vials instead of bivalent vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (26 doses administered to adult patients from pediatric vials instead of bivalent vaccine).    Concomitant medication not reported. Treatment medication not reported.
The patient was found dead in his home on 3/18/2021, 8 days after vaccination. Due to the remoteness of where the individual lives and his lack of housemate, it is unknown how long he had been dead, but it is not believe that he was dead for more than 1-2 days. He had no adverse reactions in the 15-30 minutes that he was observed post-injection. He also reported only a sore arm to the public health nurse in an email a few days after his vaccination.
I started getting symptoms of shakiness with chills. I developed a sore throat, allergy symptoms, and cough. I took a COVID-19 test that was positive. I had chest pain and my lungs hurt. I called my doctor and was prescribed Paxlovid. My symptoms lasted 3 days after the Paxlovid but the cough was persistent. I had a cough for months. I had brain fog that lasted for months as well. I still feel the exhaustion. but it is improving.
tingling in toes, and legs... slight dizziness at times  heaviness and later the next week feeling as if his brain cannot tell his legs what to do.
Information has been received from a nurse in a physician's office concerning a 23 month old female with no pre-existing allergies or medical conditions who on 28Jun04 at 09:00AM was vaccinated in the right arm with the first dose of varicella virus vaccine live (lot646665/0712N). Concomitant vaccinations given on that same day at the same time included: the first dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 646555/0812N) given in the left arm and the fourth dose of diphtheria toxoid (+) Hib conj vaccine (tet toxoid) (+) pertussis acellular Biken vaccine (+) tetanus toxoid (Trihibit) (lot UE191AA) given in the LH. There was no illness at the time of vaccination and there were no other concomitant medications. Subsequently, the pt developed chickenpox. Unspecified medical attention was sought. As of 11May05 it was reported that she was recovering. No product quality complaint was involved. The nurse also reported that the pt's three other siblings developed chickenpox (WAES0505USA01477, 0505USA01835, and 0505USA01837). Additional information has been requested.
No additional AE information provided; The patient was administered an improperly stored dose of PNEUMOVAX23 on 9/3/2019; Information has been received from a nurse regarding a patient of unknown age and gender. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 03-SEP-2019, the patient was vaccinated with an improperly stored dose of Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) injection, for prophylaxis, lot number S004548 with expiration date in 12-AUG-2020 (route of administration, strength and anatomical location not reported).  The pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX23) was stored at a temperature of 47.3 degrees Fahrenheit (°F) for the time frame of 20 minutes. There was no previous temperature excursion and the call was because of a data logger.   No additional adverse effects reported.  This is one of several cases from the same reporter. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: No; reasonfornoneval: 81 Other; reasonfornonevalother: No information about availability; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent; Sender's Comments:  US-009507513-2005USA000302:
Patients arm became red and swollen at injection site. Site hurt to touch and was hot. Parents gave her acetaminophen for swelling and pain. In the morning swelling decreased, heat came down to body temperature, still painful to touch. Continue acetaminophen for pain.
My monthly cycle started early and it was heavier. It lasted for 30 days. The bleeding would often make me have to change a pad and tampons every hour and that lasted for several weeks even after taking my menstrual cycle birth control pill. I seen a OBGYN in December and had test did that were all negative for any diseases.
Immediate dizziness @ 10:00 AM, thought it was related to anxiety. Left after sitting for 20 minutes because I thought the "anxiety" would resolve best at home. Arrived home at 10:25 AM. My lips started itching, and then swelled along with my tongue. My throat felt tight and I tried to take an oral Benadryl. It got stuck in my throat and I was unable to swallow the pill. It was also difficult to swallow water. I arrived at the ED by 10:40 AM, where I was treated with IV Benadryl and Solu-Medrol. I remained swollen all over, especially in my fingers, for the next 4 days. I gained 12 pounds, either from the reaction or the steroids. My airway did not fully close.
Hives, that spread to the whole body, Given medications in ER and given different types of medications to take home. Antihistamine (not Benadryl) can't remember what IV drugs were given. Took a couple of weeks to go away. Not hospitalized.
Day after 2nd vaccination. Legs felt unbalanced (rubbery feelings). Stability compromised - looks like he is drunk when he is walking. 2 days after 2nd dose - fingers became numb both hands. Patient reports he: Called CDC about it. Saw PCP and ran some tests, but no answers. Dr.  Called a neurologist - don't want to see him unless referred by a PCP. Seeing another neurologist on 7th of June.